Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNFS621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming

被引：8
|
作者：
Bax, Monique [1 ,2 ]
Balez, Rachelle [1 ,2 ]
Munoz, Sonia Sanz [1 ,2 ]
Do-Ha, Dzung [1 ,2 ]
Stevens, Claire H. [1 ,2 ]
Berg, Tracey [1 ,2 ]
Cabral-da-Silva, Mauricio C. [1 ,2 ]
Engel, Martin [1 ,2 ]
Nicholson, Garth [3 ]
Yang, Shu [4 ]
Blair, Ian P. [4 ]
Ooi, Lezanne [1 ,2 ]
机构：
[1] Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia
[2] Univ Wollongong, Sch Chem & Mol Biosci, Wollongong, NSW 2522, Australia
[3] Univ Sydney, Concord Repatriat Gen Hosp, ANZAC Res Inst, Sydney, NSW, Australia
[4] Macquarie Univ, Fac Med & Hlth Sci, Macquarie Univ Ctr Motor Neuron Dis Res, N Ryde, NSW 2109, Australia
来源：
STEM CELL RESEARCH | 2019年 / 40卷
基金：
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词：
D O I：
10.1016/j.scr.2019.101530
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Dermal fibroblasts from a 59 year old male patient with amyotrophic lateral sclerosis (symptomatic at the time of collection), attributed to a mutation in the cyclin F gene (CCNFS621G), were reprogrammed using mRNA and microRNA-delivered OSKM factors to induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed pluripotent, expressing typical pluripotency markers and were capable of three germ layer differentiation. This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis
    Ustyantseva, E., I
    Medvedev, S. P.
    Vetchinova, A. S.
    Illarioshkin, S. N.
    Leonov, S., V
    Zakian, S. M.
    STEM CELL RESEARCH, 2020, 42
  • [32] Generation of an Induced Pluripotent Stem Cell Line TNRMCi001-A by Reprogramming Fibroblasts from a Homozygous F508del Cystic Fibrosis Patient
    Zhigalina, D. I.
    Kireeva, T. N.
    Nikitina, T. V.
    Odinokova, O. N.
    Kolesnikov, N. A.
    Malakhova, A. A.
    Savchenko, R. R.
    Zhalsanova, I. Zh.
    Valiahmetov, N. R.
    Postrigan, A. E.
    Vovk, S. L.
    Torkhova, N. B.
    Frolova, A. A.
    Stepanov, V. A.
    Skryabin, N. A.
    RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY, 2023, 54 (SUPPL 1) : S68 - S74
  • [33] Generation of an Induced Pluripotent Stem Cell Line TNRMCi001-A by Reprogramming Fibroblasts from a Homozygous F508del Cystic Fibrosis Patient
    D. I. Zhigalina
    T. N. Kireeva
    T. V. Nikitina
    O. N. Odinokova
    N. A. Kolesnikov
    A. A. Malakhova
    R. R. Savchenko
    I. Zh. Zhalsanova
    N. R. Valiahmetov
    A. E. Postrigan
    S. L. Vovk
    N. B. Torkhova
    A. A. Frolova
    V. A. Stepanov
    N. A. Skryabin
    Russian Journal of Developmental Biology, 2023, 54 : S68 - S74
  • [34] Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects
    Gubert, Fernanda
    Vasques, Juliana F.
    Cozendey, Tatiane D.
    Domizi, Pablo
    Toledo, Maria Fernanda
    Kasai-Brunswick, Tais H.
    Loureiro, Marli P. S.
    Lima, Jose M. B.
    Gress, Claudio H.
    Cabello, Giselda M. K.
    Cabello, Pedro H.
    Borgonovo, Tamara
    Vaz, Isadora M.
    Silva, Rosane
    Mendez-Otero, Rosalia
    STEM CELL RESEARCH, 2019, 37
  • [35] Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age -related macular degeneration
    Kamata, Kazuma
    Otsuka, Yuki
    Imamura, Keiko
    Oishi, Akio
    Kondo, Takayuki
    Suga, Mika
    Shibukawa, Ran
    Okanishi, Yasue
    Sagara, Yukako
    Tsukita, Kayko
    Yasukawa, Tsutomu
    Usui, Hideaki
    Muguruma, Keiko
    Tsujikawa, Akitaka
    Inoue, Haruhisa
    STEM CELL RESEARCH, 2020, 45
  • [36] Generation of a human fibroblast-derived induced pluripotent stem cell line KRIBBi009-A from a patient with breast cancer
    Son, Naeun
    Son, Ye Seul
    Jung, Cho-Rok
    Son, Mi -Young
    STEM CELL RESEARCH, 2023, 68
  • [37] Generation of a human induced pluripotent stem cell line (INNDSUi003-A) derived from patient with Becker muscular dystrophy (BMD)
    Ji, Xinbo
    Wang, Yu
    Sun, Ping
    Wang, Dongdong
    Sun, Xiaohan
    Zhang, Rui
    Xu, Jingwen
    Li, Wei
    Liu, Fuchen
    Yan, Chuanzhu
    STEM CELL RESEARCH, 2022, 62
  • [38] Generation and characterization of a human induced pluripotent stem cell line (XWHNi001-A) derived from an Alzheimer's disease patient with mutation in the APP gene
    Wei, Cuibai
    Lu, Xinliang
    Zou, Qi
    Gong, Shuting
    Chen, Yufei
    Lyu, Jihui
    Jia, Jianping
    STEM CELL RESEARCH, 2022, 60
  • [39] Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients
    Jiang, Leanne
    Tracey, Timothy J.
    Gill, Melinder K.
    Howe, Stephanie L.
    Power, Dominique T.
    Bharti, Vanda
    McCombe, Pamela A.
    Henderson, Robert D.
    Steyn, Frederik J.
    Ngo, Shyuan T.
    STEM CELL RESEARCH, 2024, 78
  • [40] Characterization of a human induced pluripotent stem cell line (FDCHi015-A) derived from PBMCs of a patient harbouring ALDOB mutation
    Yin, Tingting
    Liao, Yunfei
    Li, Xu
    Wang, Huijun
    Wu, Bingbing
    Dong, Xinran
    STEM CELL RESEARCH, 2024, 78
12345